Latest Capital Investments News

Page 10 of 43
Rio Tinto reported solid 2025 results with an 8% increase in copper equivalent production and disciplined cost management, driving a 9% rise in underlying EBITDA to $25.4 billion. The company marked major project completions and maintained a strong dividend payout.
Maxwell Dee
Maxwell Dee
19 Feb 2026
MaxiPARTS Limited reported a modest 1.8% revenue increase to $139.3 million for the half-year ended December 2025, while net profit after tax dipped slightly by 2%. The company raised its interim dividend to 4.15 cents per share, reflecting confidence in its growth initiatives and cash flow outlook.
Victor Sage
Victor Sage
19 Feb 2026
Transurban Group has reported a robust turnaround in its half-year results to December 2025, with revenue rising 8.1% and profit rebounding from a loss to $343 million. Major infrastructure projects like Melbourne’s West Gate Tunnel and Sydney’s M7-M12 integration are driving growth and operational momentum.
Nora Hopper
Nora Hopper
19 Feb 2026
Bega Cheese Limited reported a strong half-year performance with a 5% revenue increase and a 55% jump in net profit, alongside a higher interim dividend and ongoing operational consolidation.
Victor Sage
Victor Sage
19 Feb 2026
Capstone Copper forecasts steady 2026 copper output with a $495 million capital expenditure plan focused on key growth projects and exploration in Chile.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Select Harvests Limited has reported a strong FY2025 financial performance with a net profit after tax of $31.8 million and a significant reduction in net debt. The company plans to resume dividend payments in 2026 amid favourable almond market conditions.
Ada Torres
Ada Torres
17 Feb 2026
Acrow Limited reaffirms its first half FY26 revenue guidance with a 22% increase year-on-year, driven by robust demand in key Australian regions and strategic capital investments.
Victor Sage
Victor Sage
17 Feb 2026
MLG Oz Limited has delivered a robust half-year performance with revenue climbing 6% and EBITDA soaring 24.5%, underpinned by strong gold sector demand and operational efficiencies.
Maxwell Dee
Maxwell Dee
17 Feb 2026
Rhythm Biosciences has inked a non-exclusive distribution agreement with 4Cyte Pathology to integrate its ColoSTAT® colorectal cancer blood test into a vast pathology network across eastern Australia, aiming to boost adoption and accessibility.
Ada Torres
Ada Torres
17 Feb 2026
Sandon Capital Investments reported a robust 17.1% total shareholder return for the half-year ending December 2025, underpinned by rising dividends and a narrowing discount to net tangible assets. The shift to monthly fully franked dividends signals a strategic focus on steady income for investors.
Claire Turing
Claire Turing
16 Feb 2026
The a2 Milk Company has reported robust half-year results with strong revenue and earnings growth, driven by gains in infant formula and liquid milk segments, alongside a strategic supply chain transformation. The company has upgraded its full-year outlook and announced a substantial special dividend, signalling confidence in its growth trajectory.
Victor Sage
Victor Sage
16 Feb 2026
Alkane Resources Limited reported a significant jump in Q2 2026 production and revenue following its acquisition of Mandalay Resources, reaffirming its full-year guidance amid strong operational performance.
Maxwell Dee
Maxwell Dee
13 Feb 2026